Radiation for Macular Degeneration

One can tel how much time/money and effort is being placed on the problem that's facing the older generation by looking at media exposure and technological advances. Here is another report shown on KGO-TV San Francisco, an ABC affiliate, yesterday.

Macular Degenaration is the most common form of vision loss among people over 60. In a clinical trial taking place in San Jose, Calif., "a combination therapy" is "being tested by Amr Dessouki, M.D. For the trial, Dr. Dessouki will first inject patients' eyes with Lucentis (ranibizumab), a drug approved to treat wet age-related macular degeneration, that is proven to block abnormal blood vessel growth and prevent bleeding. Next, Dr. Dessouki will saturate the cluster of blood vessels with a targeted dose of radiation delivered by "a laser device about the size of a fountain pen. ... The laser radiation is calibrated precisely for the size of the lesion, and administered for a preset amount of time." Should the clinical trial be successful, the combination treatment could free patients from a life of monthly injections!